NYSE:MRT - MedEquities Realty Trust Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$7.18 +0.41 (+6.06 %)
(As of 12/19/2018 05:07 AM ET)
Previous Close$6.77
Today's Range$6.84 - $7.20
52-Week Range$6.54 - $11.85
Volume213,000 shs
Average Volume159,244 shs
Market Capitalization$224.95 million
P/E Ratio6.30
Dividend Yield11.90%
Beta0.58
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.

Receive MRT News and Ratings via Email

Sign-up to receive the latest news and ratings for MRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Current SymbolNYSE:MRT
Previous Symbol
CUSIPN/A
Phone615-627-4710

Debt

Debt-to-Equity RatioN/A
Current Ratio7.54
Quick Ratio7.54

Price-To-Earnings

Trailing P/E Ratio6.30
Forward P/E Ratio8.98
P/E GrowthN/A

Sales & Book Value

Annual Sales$61.10 million
Price / Sales3.74
Cash Flow$1.2190 per share
Price / Cash Flow5.89
Book Value$11.23 per share
Price / Book0.64

Profitability

EPS (Most Recent Fiscal Year)$1.14
Net Income$20.42 million
Net Margins19.98%
Return on Equity3.39%
Return on Assets1.97%

Miscellaneous

Employees12
Outstanding Shares31,860,000
Market Cap$224.95 million
OptionableNot Optionable

MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions

What is MedEquities Realty Trust's stock symbol?

MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT."

How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust?

MedEquities Realty Trust declared a quarterly dividend on Thursday, August 2nd. Investors of record on Wednesday, August 15th will be paid a dividend of $0.21 per share on Wednesday, August 29th. This represents a $0.84 dividend on an annualized basis and a yield of 11.70%. The ex-dividend date is Tuesday, August 14th. View MedEquities Realty Trust's Dividend History.

How were MedEquities Realty Trust's earnings last quarter?

MedEquities Realty Trust Inc (NYSE:MRT) announced its quarterly earnings data on Monday, November, 12th. The financial services provider reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.18 by $0.25. The financial services provider had revenue of $9.68 million for the quarter, compared to analysts' expectations of $17.72 million. MedEquities Realty Trust had a net margin of 19.98% and a return on equity of 3.39%. View MedEquities Realty Trust's Earnings History.

When is MedEquities Realty Trust's next earnings date?

MedEquities Realty Trust is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for MedEquities Realty Trust.

What guidance has MedEquities Realty Trust issued on next quarter's earnings?

MedEquities Realty Trust updated its FY 2018 earnings guidance on Friday, November, 9th. The company provided EPS guidance of $1.00-1.02 for the period.

What price target have analysts set for MRT?

8 brokerages have issued twelve-month price targets for MedEquities Realty Trust's stock. Their predictions range from $9.00 to $12.00. On average, they anticipate MedEquities Realty Trust's share price to reach $10.75 in the next year. This suggests a possible upside of 49.7% from the stock's current price. View Analyst Price Targets for MedEquities Realty Trust.

What is the consensus analysts' recommendation for MedEquities Realty Trust?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for MedEquities Realty Trust.

What are Wall Street analysts saying about MedEquities Realty Trust stock?

Here are some recent quotes from research analysts about MedEquities Realty Trust stock:
  • 1. According to Zacks Investment Research, "MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. " (11/23/2018)
  • 2. Cantor Fitzgerald analysts commented, "MRT reported in-line 4Q17 results and issued 2018 guidance that includes fewer acquisitions than we modeled, and we believe could be conservative. Closings have been slower industry-wide, but the backlog of announced deals is good for 2018." (2/21/2018)

Has MedEquities Realty Trust been receiving favorable news coverage?

News headlines about MRT stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MedEquities Realty Trust earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news articles about the financial services provider a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days.

Who are some of MedEquities Realty Trust's key competitors?

Who are MedEquities Realty Trust's key executives?

MedEquities Realty Trust's management team includes the folowing people:
  • Mr. John W. McRoberts, Chairman & CEO (Age 65)
  • Mr. William C. Harlan, Pres, COO & Director (Age 66)
  • Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 48)
  • Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 43)
  • Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC

When did MedEquities Realty Trust IPO?

(MRT) raised $259 million in an IPO on Thursday, September 29th 2016. The company issued 19,900,000 shares at $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.

Who are MedEquities Realty Trust's major shareholders?

MedEquities Realty Trust's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.89%), Vanguard Group Inc (9.89%), American Century Companies Inc. (7.30%), Prudential Financial Inc. (5.80%), BlackRock Inc. (5.40%) and Renaissance Technologies LLC (3.20%). Company insiders that own MedEquities Realty Trust stock include Bluemountain Capital Managemen, John W Mcroberts, Randy L Churchey and William C Harlan. View Institutional Ownership Trends for MedEquities Realty Trust.

Which major investors are selling MedEquities Realty Trust stock?

MRT stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Stadium Capital Management LLC, Man Group plc, Victory Capital Management Inc., GSA Capital Partners LLP, Wells Fargo & Company MN, NWQ Investment Management Company LLC and Moody Lynn & Lieberson LLC. View Insider Buying and Selling for MedEquities Realty Trust.

Which major investors are buying MedEquities Realty Trust stock?

MRT stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc, Vanguard Group Inc., Renaissance Technologies LLC, Putnam Investments LLC, American Century Companies Inc., Aristotle Capital Boston LLC and Bank of New York Mellon Corp. Company insiders that have bought MedEquities Realty Trust stock in the last two years include John W Mcroberts, Randy L Churchey and William C Harlan. View Insider Buying and Selling for MedEquities Realty Trust.

How do I buy shares of MedEquities Realty Trust?

Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MedEquities Realty Trust's stock price today?

One share of MRT stock can currently be purchased for approximately $7.18.

How big of a company is MedEquities Realty Trust?

MedEquities Realty Trust has a market capitalization of $224.95 million and generates $61.10 million in revenue each year. The financial services provider earns $20.42 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 12 workers across the globe.

What is MedEquities Realty Trust's official website?

The official website for MedEquities Realty Trust is http://www.medequities.com.

How can I contact MedEquities Realty Trust?

MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected]


MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  196 (Vote Underperform)
Total Votes:  365
MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel